Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Liesner

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 14, 2015
How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous accessA Nijdam, K Kurnik, R Liesner, et al.
British Journal of Haematology|September 6, 2000
Central venous access devices in children with congenital coagulation disorders: complications and long-term outcomeC McMahon, J Smith, K Khair, et al.
Clinical and Laboratory Haematology|August 16, 2002
The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunctionPaul Harrison, M Robinson, R Liesner, et al.
Journal of the Royal Society of Medicine|February 24, 2001
Hermansky-Pudlak syndrome presenting with subdural haematoma and retinal haemorrhages in infancyI M Russell-Eggitt, D A Thompson, K Khair, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2013
The first recombinant FVIII produced in human cells--an update on its clinical development programmeL A Valentino, C Negrier, G Kohla, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2010
Factor XIII--an under diagnosed deficiency--are we using the right assays?A S Lawrie, L Green, I J Mackie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 12, 2010
Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia BP E Monahan, R Liesner, S T Sullivan, et al.
British Journal of Haematology|February 13, 2001
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpuraS L Allford, P Harrison, A S Lawrie, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2009
Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohortP W Collins, M Mathias, J Hanley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2014
Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia RegistryK Fischer, R Ljung, H Platokouki, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 14, 2015
How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous accessA Nijdam, K Kurnik, R Liesner, et al.
British Journal of Haematology|September 6, 2000
Central venous access devices in children with congenital coagulation disorders: complications and long-term outcomeC McMahon, J Smith, K Khair, et al.
Clinical and Laboratory Haematology|August 16, 2002
The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunctionPaul Harrison, M Robinson, R Liesner, et al.
Journal of the Royal Society of Medicine|February 24, 2001
Hermansky-Pudlak syndrome presenting with subdural haematoma and retinal haemorrhages in infancyI M Russell-Eggitt, D A Thompson, K Khair, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2013
The first recombinant FVIII produced in human cells--an update on its clinical development programmeL A Valentino, C Negrier, G Kohla, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2010
Factor XIII--an under diagnosed deficiency--are we using the right assays?A S Lawrie, L Green, I J Mackie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 12, 2010
Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia BP E Monahan, R Liesner, S T Sullivan, et al.
British Journal of Haematology|February 13, 2001
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpuraS L Allford, P Harrison, A S Lawrie, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2009
Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohortP W Collins, M Mathias, J Hanley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2014
Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia RegistryK Fischer, R Ljung, H Platokouki, et al.
Pageof 7